These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34904368)

  • 1. Measurement invariance testing of longitudinal neuropsychiatric test scores distinguishes pathological from normative cognitive decline and highlights its potential in early detection research.
    Haberstumpf S; Forster A; Leinweber J; Rauskolb S; Hewig J; Sendtner M; Lauer M; Polak T; Deckert J; Herrmann MJ
    J Neuropsychol; 2022 Jun; 16(2):324-352. PubMed ID: 34904368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance.
    Chang M; Brainerd CJ
    Neuropsychology; 2021 May; 35(4):434-450. PubMed ID: 34043393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Factor Structure and Measurement Invariance of the NIH Toolbox Cognition Battery in an Alzheimer's Disease Research Sample.
    Ma Y; Carlsson CM; Wahoske ML; Blazel HM; Chappell RJ; Johnson SC; Asthana S; Gleason CE
    J Int Neuropsychol Soc; 2021 May; 27(5):412-425. PubMed ID: 33012297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.
    Dowling NM; Hermann B; La Rue A; Sager MA
    Neuropsychology; 2010 Nov; 24(6):742-756. PubMed ID: 21038965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease.
    Donovan NJ; Amariglio RE; Zoller AS; Rudel RK; Gomez-Isla T; Blacker D; Hyman BT; Locascio JJ; Johnson KA; Sperling RA; Marshall GA; Rentz DM
    Am J Geriatr Psychiatry; 2014 Dec; 22(12):1642-51. PubMed ID: 24698445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with dropout in the longitudinal Vogel study of cognitive decline.
    Haberstumpf S; Leinweber J; Lauer M; Polak T; Deckert J; Herrmann MJ
    Eur J Neurosci; 2022 Nov; 56(9):5587-5600. PubMed ID: 34490950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal change in neuropsychological performance using latent growth models: a study of mild cognitive impairment.
    Johnson JK; Gross AL; Pa J; McLaren DG; Park LQ; Manly JJ;
    Brain Imaging Behav; 2012 Dec; 6(4):540-50. PubMed ID: 22562439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.
    Hayden KM; Kuchibhatla M; Romero HR; Plassman BL; Burke JR; Browndyke JN; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1364-74. PubMed ID: 24080384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring cognitive change in subjects with prodromal Alzheimer's disease.
    Mura T; Proust-Lima C; Jacqmin-Gadda H; Akbaraly TN; Touchon J; Dubois B; Berr C
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):363-70. PubMed ID: 23840054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    Poptsi E; Tsardoulias E; Moraitou D; Symeonidis AL; Tsolaki M
    J Alzheimers Dis; 2019; 72(3):783-801. PubMed ID: 31640100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive factor structure and measurement invariance between healthy controls and patients with major depressive disorder.
    Yang KC; Hsieh WC; Chou YH
    J Psychiatr Res; 2022 Jul; 151():598-605. PubMed ID: 35636038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.
    Forstmeier S; Maercker A
    BMC Psychiatry; 2015 Nov; 15():293. PubMed ID: 26578083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.